Eosinophilia - 48 Studies Found Completed : The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia : Eosinophilic Pneumonia Chronic Disease : 2008-02-28 : Drug: prednisolone 0.5 mg/kg/day for three months Completed : A Phase IIa Study of KHK4563 : Uncontrolled and Suspected Eosinophilic Asthma : 2011-08-07 : Drug: KHK4563 every 4 weeks fo Recruiting : Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma : Severe Eosinophilic Asthma : 2015-09-04 : Drug: OC000459 Drug: Placebo Completed : Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma : Eosinophilic Asthma : 2012-01-03 : Drug: Reslizumab Reslizumab ad Active, not recruiting : Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study : Asthma : 2015-08-31 : Drug: Mepolizumab 100 mg SC ev Recruiting : Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients : Asthma : 2015-09-17 : Biological: Mepolizumab 100mg Completed : Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control : Asthma : 2014-10-30 : Biological: Mepolizumab Humani Active, not recruiting : Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients : Asthma : 2016-01-11 : Drug: Mepolizumab 100mg SC At Recruiting : A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma : Eosinophils, Asthma : 2017-02-07 : Drug: reslizumab 110-mg Completed : Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma : Asthma : 2011-03-09 : Biological: SAR231893 (REGN668) <<< Previous | Next >>>